The whole-brain pattern of magnetic susceptibility perturbations in Parkinson’s disease

Although iron-mediated oxidative stress has been proposed as a potential pathomechanism in Parkinson's disease, the global distribution of iron accumulation in Parkinson's disease has not yet been elucidated. This study used a new magnetic resonance imaging contrast, quantitative susceptib...

Full description

Saved in:
Bibliographic Details
Published inBrain (London, England : 1878) Vol. 140; no. 1; pp. 118 - 131
Main Authors Acosta-Cabronero, Julio, Cardenas-Blanco, Arturo, Betts, Matthew J., Butryn, Michaela, Valdes-Herrera, Jose P., Galazky, Imke, Nestor, Peter J.
Format Journal Article
LanguageEnglish
Published England 01.01.2017
Subjects
Online AccessGet full text
ISSN0006-8950
1460-2156
DOI10.1093/brain/aww278

Cover

Abstract Although iron-mediated oxidative stress has been proposed as a potential pathomechanism in Parkinson's disease, the global distribution of iron accumulation in Parkinson's disease has not yet been elucidated. This study used a new magnetic resonance imaging contrast, quantitative susceptibility mapping, and state-of-the-art methods to map for the first time the whole-brain landscape of magnetostatic alterations as a surrogate for iron level changes in n = 25 patients with idiopathic Parkinson's disease versus n = 50 matched controls. In addition to whole-brain analysis, a regional study including sub-segmentation of the substantia nigra into dorsal and ventral regions and qualitative assessment of susceptibility maps in single subjects were also performed. The most remarkable basal ganglia effect was an apparent magnetic susceptibility increase-consistent with iron deposition-in the dorsal substantia nigra, though an effect was also observed in ventral regions. Increased bulk susceptibility, additionally, was detected in rostral pontine areas and in a cortical pattern tightly concordant with known Parkinson's disease distributions of α-synuclein pathology. In contrast, the normally iron-rich cerebellar dentate nucleus returned a susceptibility reduction suggesting decreased iron content. These results are in agreement with previous post-mortem studies in which iron content was evaluated in specific regions of interest; however, extensive neocortical and cerebellar changes constitute a far more complex pattern of iron dysregulation than was anticipated. Such findings also stand in stark contrast to the lack of statistically significant group change using conventional magnetic resonance imaging methods namely voxel-based morphometry, cortical thickness analysis, subcortical volumetry and tract-based diffusion tensor analysis; confirming the potential of whole-brain quantitative susceptibility mapping as an in vivo biomarker in Parkinson's disease.
AbstractList Although iron-mediated oxidative stress has been proposed as a potential pathomechanism in Parkinson's disease, the global distribution of iron accumulation in Parkinson's disease has not yet been elucidated. This study used a new magnetic resonance imaging contrast, quantitative susceptibility mapping, and state-of-the-art methods to map for the first time the whole-brain landscape of magnetostatic alterations as a surrogate for iron level changes in n = 25 patients with idiopathic Parkinson's disease versus n = 50 matched controls. In addition to whole-brain analysis, a regional study including sub-segmentation of the substantia nigra into dorsal and ventral regions and qualitative assessment of susceptibility maps in single subjects were also performed. The most remarkable basal ganglia effect was an apparent magnetic susceptibility increase-consistent with iron deposition-in the dorsal substantia nigra, though an effect was also observed in ventral regions. Increased bulk susceptibility, additionally, was detected in rostral pontine areas and in a cortical pattern tightly concordant with known Parkinson's disease distributions of α-synuclein pathology. In contrast, the normally iron-rich cerebellar dentate nucleus returned a susceptibility reduction suggesting decreased iron content. These results are in agreement with previous post-mortem studies in which iron content was evaluated in specific regions of interest; however, extensive neocortical and cerebellar changes constitute a far more complex pattern of iron dysregulation than was anticipated. Such findings also stand in stark contrast to the lack of statistically significant group change using conventional magnetic resonance imaging methods namely voxel-based morphometry, cortical thickness analysis, subcortical volumetry and tract-based diffusion tensor analysis; confirming the potential of whole-brain quantitative susceptibility mapping as an in vivo biomarker in Parkinson's disease.
Author Cardenas-Blanco, Arturo
Butryn, Michaela
Nestor, Peter J.
Valdes-Herrera, Jose P.
Galazky, Imke
Acosta-Cabronero, Julio
Betts, Matthew J.
Author_xml – sequence: 1
  givenname: Julio
  surname: Acosta-Cabronero
  fullname: Acosta-Cabronero, Julio
– sequence: 2
  givenname: Arturo
  surname: Cardenas-Blanco
  fullname: Cardenas-Blanco, Arturo
– sequence: 3
  givenname: Matthew J.
  surname: Betts
  fullname: Betts, Matthew J.
– sequence: 4
  givenname: Michaela
  surname: Butryn
  fullname: Butryn, Michaela
– sequence: 5
  givenname: Jose P.
  surname: Valdes-Herrera
  fullname: Valdes-Herrera, Jose P.
– sequence: 6
  givenname: Imke
  surname: Galazky
  fullname: Galazky, Imke
– sequence: 7
  givenname: Peter J.
  surname: Nestor
  fullname: Nestor, Peter J.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27836833$$D View this record in MEDLINE/PubMed
BookMark eNpt0LtOwzAUgGELFdELbMwoIwOhPnHiOCOquEmVYCgDU2Qnp9SQOsF2VHXjNXg9noT0AgNiso70nSPrH5KeqQ0Scgr0EmjGxspKbcZytYpScUAGEHMaRpDwHhlQSnkosoT2ydC5V0ohZhE_Iv2OMi4YG5Dn2QKD1aKuMNweChrpPVoT1PNgKV8Mel0ErnUFNl4rXWm_Dhq0vrVKel0bF3Q7j9K-aeNq8_Xx6YJSO5QOj8nhXFYOT_bviDzdXM8md-H04fZ-cjUNC5YlPhQ8S1UslBCIvGBplILKKKelKlWaIkeIEkxFKpWKSlAiSRJQMQBE3aAKYCNyvrvb2Pq9Refzpe6-W1XSYN26HATLABLGNvRsT1u1xDJvrF5Ku85_cnTgYgcKWztncf5LgOab2vk2Ur6r3fHoDy-032bxHav-X_oG1oWHZQ
CitedBy_id crossref_primary_10_1002_nbm_4292
crossref_primary_10_1007_s11684_019_0725_5
crossref_primary_10_1016_j_nicl_2018_07_028
crossref_primary_10_1016_j_fct_2019_05_038
crossref_primary_10_1111_jon_12957
crossref_primary_10_1007_s00429_022_02547_1
crossref_primary_10_1016_j_clineuro_2020_106181
crossref_primary_10_3389_fendo_2022_844351
crossref_primary_10_1016_j_banm_2019_04_019
crossref_primary_10_1016_j_neuroimage_2019_03_060
crossref_primary_10_1002_nbm_4571
crossref_primary_10_1002_mrm_28185
crossref_primary_10_3389_fnins_2023_1165446
crossref_primary_10_1002_mrm_29958
crossref_primary_10_1142_S0219519421400261
crossref_primary_10_1002_jmri_25693
crossref_primary_10_1038_s41531_024_00758_3
crossref_primary_10_1007_s00702_017_1695_x
crossref_primary_10_1002_mds_29123
crossref_primary_10_1097_WCO_0000000000000463
crossref_primary_10_1097_WCO_0000000000000584
crossref_primary_10_1186_s12868_017_0369_9
crossref_primary_10_3389_fnins_2021_618435
crossref_primary_10_1016_j_neuroimage_2024_120583
crossref_primary_10_3348_jksr_2022_0044
crossref_primary_10_1016_j_nicl_2021_102831
crossref_primary_10_1007_s00234_017_1813_3
crossref_primary_10_1109_TMI_2023_3305378
crossref_primary_10_1016_j_media_2024_103173
crossref_primary_10_1111_bpa_13288
crossref_primary_10_1002_mds_27730
crossref_primary_10_1002_nbm_4272
crossref_primary_10_1002_ana_25376
crossref_primary_10_1016_j_ejmp_2022_09_012
crossref_primary_10_1038_s41467_024_49949_9
crossref_primary_10_1016_j_neuroimage_2019_116018
crossref_primary_10_1016_j_radi_2025_102903
crossref_primary_10_1186_s13195_020_00612_7
crossref_primary_10_3389_fncir_2019_00050
crossref_primary_10_1002_mds_27929
crossref_primary_10_1016_j_neuroimage_2018_07_065
crossref_primary_10_1002_mrm_29218
crossref_primary_10_1002_mds_29702
crossref_primary_10_1016_j_media_2024_103160
crossref_primary_10_1016_j_neuroimage_2018_04_047
crossref_primary_10_1016_j_zemedi_2021_06_004
crossref_primary_10_3390_ph15050551
crossref_primary_10_1097_CM9_0000000000003167
crossref_primary_10_1093_sleep_zsab131
crossref_primary_10_1007_s00330_023_10283_1
crossref_primary_10_2463_mrms_tn_2018_0066
crossref_primary_10_1002_jmri_26161
crossref_primary_10_1093_brain_awab084
crossref_primary_10_1016_j_neuroimage_2019_05_004
crossref_primary_10_1111_ene_15447
crossref_primary_10_1002_jmri_26279
crossref_primary_10_1016_j_neuroimage_2022_119410
crossref_primary_10_1109_TVCG_2021_3137174
crossref_primary_10_1002_mrm_29048
crossref_primary_10_3389_fnagi_2020_610962
crossref_primary_10_1016_j_lfs_2023_121508
crossref_primary_10_1016_j_nicl_2024_103577
crossref_primary_10_1016_j_nicl_2019_101999
crossref_primary_10_1097_MD_0000000000021403
crossref_primary_10_1093_brain_awy211
crossref_primary_10_1016_j_nicl_2023_103394
crossref_primary_10_3988_jcn_2018_14_1_90
crossref_primary_10_1016_j_zemedi_2022_08_001
crossref_primary_10_1148_radiol_2021203341
crossref_primary_10_1002_hbm_25556
crossref_primary_10_1093_brain_awx245
crossref_primary_10_12677_ACM_2022_126738
crossref_primary_10_1002_jmri_26984
crossref_primary_10_1148_radiol_2018180112
crossref_primary_10_1002_jmri_29698
crossref_primary_10_1016_j_neuroimage_2022_119842
crossref_primary_10_1007_s00330_023_09411_8
crossref_primary_10_1109_TMI_2023_3294182
crossref_primary_10_3389_fnagi_2025_1504733
crossref_primary_10_1007_s00702_020_02271_2
crossref_primary_10_1016_j_nicl_2022_102989
crossref_primary_10_1007_s00330_018_5419_x
crossref_primary_10_1136_jnnp_2019_322042
crossref_primary_10_3389_fnins_2022_938092
crossref_primary_10_1016_j_neuroimage_2017_09_042
crossref_primary_10_1259_bjr_20210809
crossref_primary_10_1002_mds_27705
crossref_primary_10_1002_mds_28077
crossref_primary_10_1016_j_parkreldis_2018_07_011
crossref_primary_10_1016_j_neurobiolaging_2018_11_013
crossref_primary_10_1016_j_neuroimage_2023_120148
crossref_primary_10_1016_j_compeleceng_2021_107091
crossref_primary_10_1016_j_neuroimage_2024_120547
crossref_primary_10_1007_s10534_018_0131_5
crossref_primary_10_1007_s00330_022_08790_8
crossref_primary_10_1021_acschemneuro_7b00247
crossref_primary_10_3389_fneur_2020_572976
crossref_primary_10_3389_fneur_2024_1407860
crossref_primary_10_1007_s00702_019_02138_1
crossref_primary_10_1002_hbm_26675
crossref_primary_10_1016_j_freeradbiomed_2023_12_005
crossref_primary_10_1111_ejn_14756
crossref_primary_10_3389_fneur_2021_631210
crossref_primary_10_1002_jmri_29569
crossref_primary_10_1016_j_nicl_2021_102637
crossref_primary_10_3389_fnagi_2022_909552
crossref_primary_10_1016_j_neuroimage_2021_118404
crossref_primary_10_1016_j_pnpbp_2023_110903
crossref_primary_10_1016_j_praneu_2019_01_008
crossref_primary_10_30773_pi_2022_0110
crossref_primary_10_1002_nbm_3798
crossref_primary_10_1016_j_nicl_2020_102185
crossref_primary_10_18632_aging_202368
crossref_primary_10_1038_s41582_022_00618_9
crossref_primary_10_1093_brain_awaa089
crossref_primary_10_1002_hbm_25770
crossref_primary_10_1016_j_mri_2018_06_006
crossref_primary_10_1186_s12868_019_0505_9
crossref_primary_10_1016_j_neuroimage_2024_120892
crossref_primary_10_3233_JPD_212833
crossref_primary_10_1016_j_neuroimage_2022_119503
crossref_primary_10_1111_ene_15754
crossref_primary_10_1002_mp_17747
crossref_primary_10_1016_j_bspc_2024_107446
crossref_primary_10_3389_fncel_2022_1005182
crossref_primary_10_1002_nbm_4517
crossref_primary_10_1007_s13538_022_01098_4
crossref_primary_10_1016_j_neuroimage_2021_118574
crossref_primary_10_1016_j_mri_2018_04_004
crossref_primary_10_1002_hbm_26178
crossref_primary_10_1007_s00702_024_02856_1
crossref_primary_10_1007_s12264_017_0138_x
crossref_primary_10_1002_nbm_4461
crossref_primary_10_1016_j_dadm_2019_04_010
crossref_primary_10_1038_s41531_022_00347_2
crossref_primary_10_1002_mds_27717
crossref_primary_10_1007_s40263_019_00668_6
crossref_primary_10_3174_ajnr_A7822
crossref_primary_10_1016_j_mri_2018_10_001
crossref_primary_10_1093_braincomms_fcab306
crossref_primary_10_3389_fnagi_2019_00106
crossref_primary_10_3389_fnins_2021_647168
crossref_primary_10_1016_j_ibneur_2025_01_003
crossref_primary_10_1007_s00115_017_0289_z
crossref_primary_10_1002_mds_27275
crossref_primary_10_1093_brain_awab274
crossref_primary_10_1002_mrm_27509
Cites_doi 10.1007/s00702-012-0873-0
10.1002/ana.22592
10.1093/brain/awl388
10.1016/j.jns.2012.11.009
10.1371/journal.pone.0112638
10.1016/j.neuroimage.2012.05.049
10.1093/brain/114.5.2283
10.1016/j.neuroimage.2011.02.046
10.1016/S0197-4580(02)00065-9
10.1155/2014/581256
10.1016/j.neurobiolaging.2013.09.034
10.1002/mds.26043
10.1002/(SICI)1522-2594(200005)43:5<682::AID-MRM10>3.0.CO;2-G
10.1093/brain/aww022
10.1212/WNL.0b013e31829e6fd2
10.1007/s00702-012-0898-4
10.1111/j.1471-4159.1991.tb02017.x
10.1016/j.neuroimage.2008.03.061
10.1093/brain/114.4.1953
10.1038/334345a0
10.1148/radiology.172.2.2748838
10.1212/01.wnl.0000262033.01945.9a
10.1111/j.1552-6569.2008.00246.x
10.1016/j.neuroimage.2010.10.070
10.1111/j.1471-4159.1958.tb12607.x
10.1093/brain/122.4.667
10.1111/j.1471-4159.2010.07132.x
10.3174/ajnr.A4260
10.1016/j.neuroimage.2013.04.022
10.1093/brain/awv361
10.1136/jnnp.55.3.181
10.1016/j.neuroimage.2014.11.010
10.1002/nbm.3489
10.1093/brain/122.8.1437
10.1111/j.1471-4159.1989.tb09150.x
10.1002/nbm.3554
10.1523/JNEUROSCI.20-16-06048.2000
10.1016/j.tics.2013.03.003
10.1016/0006-8993(92)91334-B
10.1016/S1474-4422(14)70117-6
10.1016/j.neuroimage.2016.05.024
10.1073/pnas.0911177107
10.1007/s12640-010-9187-x
10.1016/j.jtemb.2013.09.006
10.3389/fnins.2012.00171
10.1371/journal.pone.0112512
10.1002/mrm.24272
10.1212/01.wnl.0000286384.31050.b5
10.1523/JNEUROSCI.1907-15.2016
10.1093/brain/aws360
10.1016/0022-3956(75)90026-6
10.1002/hbm.22928
10.1016/S0140-6736(14)60357-3
10.1016/j.neuroimage.2014.02.026
10.1002/mrm.10171
10.1016/j.neuroimage.2014.01.060
10.1093/brain/awv136
10.1016/j.neuroimage.2006.02.024
10.1364/OL.28.001194
10.1007/s00441-004-0956-9
10.1371/journal.pone.0035397
10.1088/0031-9155/54/3/012
10.1016/j.mri.2015.02.021
10.1002/ana.1133
ContentType Journal Article
Copyright The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Copyright_xml – notice: The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1093/brain/aww278
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1460-2156
EndPage 131
ExternalDocumentID 27836833
10_1093_brain_aww278
Genre Journal Article
GroupedDBID ---
-E4
-~X
.2P
.55
.GJ
.I3
.XZ
.ZR
0R~
1CY
1TH
23N
2WC
354
3O-
4.4
41~
482
48X
53G
5GY
5RE
5VS
5WA
5WD
6PF
70D
AABZA
AACZT
AAGKA
AAIMJ
AAJKP
AAJQQ
AAMDB
AAMVS
AAOGV
AAPGJ
AAPNW
AAPQZ
AAPXW
AAQQT
AARHZ
AAUAY
AAUQX
AAVAP
AAVLN
AAWDT
AAWTL
AAYJJ
AAYXX
ABDFA
ABDPE
ABEJV
ABEUO
ABGNP
ABIME
ABIVO
ABIXL
ABJNI
ABKDP
ABLJU
ABMNT
ABNGD
ABNHQ
ABNKS
ABPIB
ABPQP
ABPTD
ABQLI
ABQNK
ABSMQ
ABVGC
ABWST
ABXVV
ABXZS
ABZBJ
ABZEO
ACBNA
ACFRR
ACGFS
ACIWK
ACPQN
ACPRK
ACUFI
ACUKT
ACUTJ
ACUTO
ACVCV
ACYHN
ACZBC
ADBBV
ADEYI
ADEZT
ADGKP
ADGZP
ADHKW
ADHZD
ADIPN
ADMTO
ADNBA
ADOCK
ADQBN
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEHUL
AEJOX
AEKPW
AEKSI
AELWJ
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFNX
AFFQV
AFFZL
AFGWE
AFIYH
AFOFC
AFSHK
AFXAL
AFYAG
AGINJ
AGKEF
AGKRT
AGMDO
AGORE
AGQPQ
AGQXC
AGSYK
AGUTN
AHGBF
AHMBA
AHMMS
AHXPO
AI.
AIJHB
AJBYB
AJDVS
AJEEA
AJNCP
AKWXX
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
ANFBD
APIBT
APJGH
APWMN
AQDSO
AQKUS
ARIXL
ASAOO
ASPBG
ATDFG
ATGXG
ATTQO
AVNTJ
AVWKF
AXUDD
AYOIW
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BQDIO
BR6
BSWAC
BTRTY
BVRKM
BZKNY
C1A
C45
CAG
CDBKE
CITATION
COF
CS3
CXTWN
CZ4
DAKXR
DFGAJ
DIK
DILTD
DU5
D~K
E3Z
EBS
EE~
EIHJH
EJD
ELUNK
EMOBN
ENERS
F5P
F9B
FECEO
FEDTE
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HVGLF
HW0
HZ~
IOX
J21
J5H
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
M-Z
MBLQV
MBTAY
MHKGH
ML0
MVM
N4W
N9A
NGC
NLBLG
NOMLY
NOYVH
NTWIH
NU-
NVLIB
O0~
O9-
OAUYM
OAWHX
OBFPC
OBOKY
OCZFY
ODMLO
OHH
OHT
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
O~Y
P2P
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
QBD
R44
RD5
RIG
RNI
ROL
ROX
ROZ
RUSNO
RW1
RXO
RZF
RZO
TCN
TCURE
TEORI
TJX
TLC
TMA
TR2
VH1
VVN
W8F
WH7
WOQ
X7H
X7M
XJT
XOL
YAYTL
YKOAZ
YQJ
YSK
YXANX
ZCG
ZGI
ZKB
ZKX
ZXP
~91
ABQTQ
CGR
CUY
CVF
ECM
EIF
M49
NPM
7X8
ID FETCH-LOGICAL-c395t-8697b48b88ee6c37271b9060dbdb77e6e125e787abb2d1b85551b411121b8bc13
ISSN 0006-8950
IngestDate Sat Sep 27 16:55:11 EDT 2025
Thu Apr 03 06:59:02 EDT 2025
Tue Jul 01 00:46:08 EDT 2025
Thu Apr 24 22:51:19 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords movement disorders
cellular mechanisms
biomarkers
Parkinson’s disease
oxidative stress
Language English
License The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c395t-8697b48b88ee6c37271b9060dbdb77e6e125e787abb2d1b85551b411121b8bc13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://academic.oup.com/brain/article-pdf/140/1/118/23001949/aww278.pdf
PMID 27836833
PQID 1839115331
PQPubID 23479
PageCount 14
ParticipantIDs proquest_miscellaneous_1839115331
pubmed_primary_27836833
crossref_primary_10_1093_brain_aww278
crossref_citationtrail_10_1093_brain_aww278
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-01-01
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – month: 01
  year: 2017
  text: 2017-01-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Brain (London, England : 1878)
PublicationTitleAlternate Brain
PublicationYear 2017
References 2016122800401139000_140.1.118.29
2016122800401139000_140.1.118.28
2016122800401139000_140.1.118.26
2016122800401139000_140.1.118.24
Hare (2016122800401139000_140.1.118.25) 2012; 119
He (2016122800401139000_140.1.118.27) 2015; 36
2016122800401139000_140.1.118.22
2016122800401139000_140.1.118.21
2016122800401139000_140.1.118.65
2016122800401139000_140.1.118.64
2016122800401139000_140.1.118.63
2016122800401139000_140.1.118.62
2016122800401139000_140.1.118.61
2016122800401139000_140.1.118.60
2016122800401139000_140.1.118.39
Kim (2016122800401139000_140.1.118.31) 2014; 9
2016122800401139000_140.1.118.38
2016122800401139000_140.1.118.37
2016122800401139000_140.1.118.35
2016122800401139000_140.1.118.34
Schwarz (2016122800401139000_140.1.118.51) 2014; 383
2016122800401139000_140.1.118.33
2016122800401139000_140.1.118.32
2016122800401139000_140.1.118.30
2016122800401139000_140.1.118.49
2016122800401139000_140.1.118.48
2016122800401139000_140.1.118.47
2016122800401139000_140.1.118.46
2016122800401139000_140.1.118.45
Han (2016122800401139000_140.1.118.23) 2013; 325
Ostrerova-Golts (2016122800401139000_140.1.118.44) 2000; 20
2016122800401139000_140.1.118.43
2016122800401139000_140.1.118.42
2016122800401139000_140.1.118.41
2016122800401139000_140.1.118.40
2016122800401139000_140.1.118.6
2016122800401139000_140.1.118.19
2016122800401139000_140.1.118.5
2016122800401139000_140.1.118.18
2016122800401139000_140.1.118.17
2016122800401139000_140.1.118.3
2016122800401139000_140.1.118.16
2016122800401139000_140.1.118.15
2016122800401139000_140.1.118.59
2016122800401139000_140.1.118.1
2016122800401139000_140.1.118.14
2016122800401139000_140.1.118.58
2016122800401139000_140.1.118.13
2016122800401139000_140.1.118.57
2016122800401139000_140.1.118.12
2016122800401139000_140.1.118.56
2016122800401139000_140.1.118.8
2016122800401139000_140.1.118.7
Lehericy (2016122800401139000_140.1.118.36) 2014; 29
Groeger (2016122800401139000_140.1.118.20) 2012; 119
Ayton (2016122800401139000_140.1.118.2) 2014; 2014
2016122800401139000_140.1.118.11
2016122800401139000_140.1.118.55
2016122800401139000_140.1.118.10
2016122800401139000_140.1.118.54
2016122800401139000_140.1.118.53
2016122800401139000_140.1.118.52
2016122800401139000_140.1.118.50
Betts (2016122800401139000_140.1.118.4) 2016; 138
Chen (2016122800401139000_140.1.118.9) 1993; 14
References_xml – volume: 119
  start-page: 1523
  year: 2012
  ident: 2016122800401139000_140.1.118.20
  article-title: Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson's disease? Implications from MRI and TCS studies
  publication-title: J Neural Transm
  doi: 10.1007/s00702-012-0873-0
– ident: 2016122800401139000_140.1.118.34
  doi: 10.1002/ana.22592
– ident: 2016122800401139000_140.1.118.61
  doi: 10.1093/brain/awl388
– volume: 325
  start-page: 29
  year: 2013
  ident: 2016122800401139000_140.1.118.23
  article-title: Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy
  publication-title: J Neurol Sci
  doi: 10.1016/j.jns.2012.11.009
– ident: 2016122800401139000_140.1.118.63
  doi: 10.1371/journal.pone.0112638
– ident: 2016122800401139000_140.1.118.35
  doi: 10.1016/j.neuroimage.2012.05.049
– ident: 2016122800401139000_140.1.118.14
  doi: 10.1093/brain/114.5.2283
– ident: 2016122800401139000_140.1.118.45
  doi: 10.1016/j.neuroimage.2011.02.046
– ident: 2016122800401139000_140.1.118.7
  doi: 10.1016/S0197-4580(02)00065-9
– volume: 2014
  start-page: 581256
  year: 2014
  ident: 2016122800401139000_140.1.118.2
  article-title: Nigral iron elevation is an invariable feature of Parkinson's disease and is a sufficient cause of neurodegeneration
  publication-title: Biomed Res Int
  doi: 10.1155/2014/581256
– ident: 2016122800401139000_140.1.118.11
  doi: 10.1016/j.neurobiolaging.2013.09.034
– volume: 29
  start-page: 1574
  year: 2014
  ident: 2016122800401139000_140.1.118.36
  article-title: 7 Tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson's disease
  publication-title: Mov Disord
  doi: 10.1002/mds.26043
– ident: 2016122800401139000_140.1.118.59
  doi: 10.1002/(SICI)1522-2594(200005)43:5<682::AID-MRM10>3.0.CO;2-G
– ident: 2016122800401139000_140.1.118.24
  doi: 10.1093/brain/aww022
– ident: 2016122800401139000_140.1.118.5
  doi: 10.1212/WNL.0b013e31829e6fd2
– volume: 119
  start-page: 1515
  year: 2012
  ident: 2016122800401139000_140.1.118.25
  article-title: Considerations for measuring iron in post-mortem tissue of Parkinson's disease patients
  publication-title: J Neural Transm
  doi: 10.1007/s00702-012-0898-4
– ident: 2016122800401139000_140.1.118.56
  doi: 10.1111/j.1471-4159.1991.tb02017.x
– ident: 2016122800401139000_140.1.118.55
  doi: 10.1016/j.neuroimage.2008.03.061
– ident: 2016122800401139000_140.1.118.12
  doi: 10.1093/brain/114.4.1953
– ident: 2016122800401139000_140.1.118.28
  doi: 10.1038/334345a0
– ident: 2016122800401139000_140.1.118.30
  doi: 10.1148/radiology.172.2.2748838
– ident: 2016122800401139000_140.1.118.42
  doi: 10.1212/01.wnl.0000262033.01945.9a
– ident: 2016122800401139000_140.1.118.46
  doi: 10.1111/j.1552-6569.2008.00246.x
– ident: 2016122800401139000_140.1.118.52
  doi: 10.1016/j.neuroimage.2010.10.070
– ident: 2016122800401139000_140.1.118.22
  doi: 10.1111/j.1471-4159.1958.tb12607.x
– ident: 2016122800401139000_140.1.118.18
  doi: 10.1093/brain/122.4.667
– ident: 2016122800401139000_140.1.118.53
  doi: 10.1111/j.1471-4159.2010.07132.x
– ident: 2016122800401139000_140.1.118.41
  doi: 10.3174/ajnr.A4260
– ident: 2016122800401139000_140.1.118.65
  doi: 10.1016/j.neuroimage.2013.04.022
– ident: 2016122800401139000_140.1.118.47
  doi: 10.1093/brain/awv361
– ident: 2016122800401139000_140.1.118.29
  doi: 10.1136/jnnp.55.3.181
– ident: 2016122800401139000_140.1.118.58
  doi: 10.1016/j.neuroimage.2014.11.010
– ident: 2016122800401139000_140.1.118.21
  doi: 10.1002/nbm.3489
– ident: 2016122800401139000_140.1.118.10
  doi: 10.1093/brain/122.8.1437
– ident: 2016122800401139000_140.1.118.49
  doi: 10.1111/j.1471-4159.1989.tb09150.x
– ident: 2016122800401139000_140.1.118.26
  doi: 10.1002/nbm.3554
– volume: 20
  start-page: 6048
  year: 2000
  ident: 2016122800401139000_140.1.118.44
  article-title: The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.20-16-06048.2000
– ident: 2016122800401139000_140.1.118.6
  doi: 10.1016/j.tics.2013.03.003
– ident: 2016122800401139000_140.1.118.17
  doi: 10.1016/0006-8993(92)91334-B
– ident: 2016122800401139000_140.1.118.60
  doi: 10.1016/S1474-4422(14)70117-6
– volume: 138
  start-page: 43
  year: 2016
  ident: 2016122800401139000_140.1.118.4
  article-title: High-resolution characterisation of the aging brain using simultaneous quantitative susceptibility mapping (QSM) and R2* measurements at 7 T
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2016.05.024
– ident: 2016122800401139000_140.1.118.16
  doi: 10.1073/pnas.0911177107
– ident: 2016122800401139000_140.1.118.37
  doi: 10.1007/s12640-010-9187-x
– ident: 2016122800401139000_140.1.118.33
  doi: 10.1016/j.jtemb.2013.09.006
– ident: 2016122800401139000_140.1.118.32
  doi: 10.3389/fnins.2012.00171
– volume: 9
  start-page: e112512
  year: 2014
  ident: 2016122800401139000_140.1.118.31
  article-title: Serum uric acid and nigral iron deposition in Parkinson's disease: a pilot study
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0112512
– ident: 2016122800401139000_140.1.118.38
  doi: 10.1002/mrm.24272
– ident: 2016122800401139000_140.1.118.39
  doi: 10.1212/01.wnl.0000286384.31050.b5
– ident: 2016122800401139000_140.1.118.1
  doi: 10.1523/JNEUROSCI.1907-15.2016
– ident: 2016122800401139000_140.1.118.64
  doi: 10.1093/brain/aws360
– ident: 2016122800401139000_140.1.118.15
  doi: 10.1016/0022-3956(75)90026-6
– volume: 36
  start-page: 4407
  year: 2015
  ident: 2016122800401139000_140.1.118.27
  article-title: Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping
  publication-title: Hum Brain Mapp
  doi: 10.1002/hbm.22928
– volume: 383
  start-page: s94
  year: 2014
  ident: 2016122800401139000_140.1.118.51
  article-title: Nigrosome imaging with T2*-weighted 3T MRI as a diagnostic marker of Parkinson's disease: a case-control and cross-sectional study of diagnostic accuracy
  publication-title: Lancet
  doi: 10.1016/S0140-6736(14)60357-3
– ident: 2016122800401139000_140.1.118.57
  doi: 10.1016/j.neuroimage.2014.02.026
– ident: 2016122800401139000_140.1.118.19
  doi: 10.1002/mrm.10171
– ident: 2016122800401139000_140.1.118.62
  doi: 10.1016/j.neuroimage.2014.01.060
– ident: 2016122800401139000_140.1.118.43
  doi: 10.1093/brain/awv136
– ident: 2016122800401139000_140.1.118.54
  doi: 10.1016/j.neuroimage.2006.02.024
– ident: 2016122800401139000_140.1.118.50
  doi: 10.1364/OL.28.001194
– ident: 2016122800401139000_140.1.118.8
  doi: 10.1007/s00441-004-0956-9
– volume: 14
  start-page: 275
  year: 1993
  ident: 2016122800401139000_140.1.118.9
  article-title: MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease
  publication-title: AJNR Am J Neuroradiol
– ident: 2016122800401139000_140.1.118.13
  doi: 10.1371/journal.pone.0035397
– ident: 2016122800401139000_140.1.118.48
  doi: 10.1088/0031-9155/54/3/012
– ident: 2016122800401139000_140.1.118.3
  doi: 10.1016/j.mri.2015.02.021
– ident: 2016122800401139000_140.1.118.40
  doi: 10.1002/ana.1133
SSID ssj0014326
Score 2.5925918
Snippet Although iron-mediated oxidative stress has been proposed as a potential pathomechanism in Parkinson's disease, the global distribution of iron accumulation in...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 118
SubjectTerms Aged
Cerebellar Nuclei - diagnostic imaging
Cerebellar Nuclei - metabolism
Female
Humans
Iron - metabolism
Magnetic Resonance Imaging - methods
Male
Middle Aged
Parkinson Disease - diagnostic imaging
Parkinson Disease - metabolism
Substantia Nigra - diagnostic imaging
Substantia Nigra - metabolism
Title The whole-brain pattern of magnetic susceptibility perturbations in Parkinson’s disease
URI https://www.ncbi.nlm.nih.gov/pubmed/27836833
https://www.proquest.com/docview/1839115331
Volume 140
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1460-2156
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0014326
  issn: 0006-8950
  databaseCode: KQ8
  dateStart: 19960101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1460-2156
  dateEnd: 20241001
  omitProxy: true
  ssIdentifier: ssj0014326
  issn: 0006-8950
  databaseCode: DIK
  dateStart: 19960101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1460-2156
  dateEnd: 20241001
  omitProxy: true
  ssIdentifier: ssj0014326
  issn: 0006-8950
  databaseCode: GX1
  dateStart: 19960101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaWIiEuiDfLS0bicahM83ScI1u1VKgtl12xt8iTOFzQpmwSrco_4F8zE-cpWqlwiZLIsXc9n2bG82TsLYpsE8RaCxSnoQhSpYVWWoo4cyMdOiDzJkPu7FyerIIv63A9m_0eRS3VFXxMf12ZV_I_VMV3SFfKkv0HyvaT4gu8R_riFSmM1xvTeEcNbgVQpwcqkkr2vcZnrr9vKD9xv6zLJnKlCYK9pDLFKGRgCCGntOc2AywqJ_6avuwRTX1V5w9rTlCRGpsT0gL1TXGoYUslkIouB7sYnB2UN6FLscApUptkQz-pH7AwVWVN4LYV-eC4WtTV9nIc7K_HNgs3GtksjOWzgXQEahtywoht4aYJ4ixbdVsebSW0a-XGX8zfFsZqNpwk3G7nRWoQc51r__xrcrw6PU2WR-vl-4ufghqQkaO-7cZyi932IimpGcbndR8thFqlJ9u8CVzmoFnkwC4x1WiuOaY06sryPrvXnjP4JwuaB2xmNg_ZnbM2kuIR-4bY4SPs8BY7vMh5hx0-xQ6fYIfjNz12PpS8Rc5jtjo-Wh6eiLbJhkj9OKyEknEEgQKljJGpj-qsC7EjnQwyiCIjDWrABrm6BvAyF1SIKjYEKCE9fIDU9Z-wvQ0C6hnjeR5nDnjSz3InCECDNHTgSJXKwEfJO2f73UYlaVuBnhqh_EhsJISfNH84sds6Z-_60Re28so14950e54gayR_l96Yoi4TUv5dOs-4c_bUEqOfiRrMSOX7z2_w9Qt2dwDxS7ZXbWvzClXRCl43IPkDeDGSUA
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+whole-brain+pattern+of+magnetic+susceptibility+perturbations+in+Parkinson%27s+disease&rft.jtitle=Brain+%28London%2C+England+%3A+1878%29&rft.au=Acosta-Cabronero%2C+Julio&rft.au=Cardenas-Blanco%2C+Arturo&rft.au=Betts%2C+Matthew+J&rft.au=Butryn%2C+Michaela&rft.date=2017-01-01&rft.eissn=1460-2156&rft.volume=140&rft.issue=1&rft.spage=118&rft.epage=131&rft_id=info:doi/10.1093%2Fbrain%2Faww278&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-8950&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-8950&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-8950&client=summon